Please use this identifier to cite or link to this item: doi:10.22028/D291-41140
Title: Toxic plants-Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometry
Author(s): Vollmer, Aline C.
Wagmann, Lea
Meyer, Markus R.
Language: English
Title: Drug Testing and Analysis
Volume: 14 (2022)
Issue: 2
Pages: 377-381
Publisher/Platform: Wiley
Year of Publication: 2021
Free key words: colchicine
liquid chromatography
mass spectrometry
systematic screening
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Colchicum autumnale, which can be mistaken for Allium ursinum, contains the alkaloid colchicine potentially leading to life-threatening up to fatal intoxications. We report two cases of acute intoxications with unexplained circumstances. Using the authors' systematic screening approaches, colchicine could be detected in blood plasma and urine samples using liquid chromatography coupled to linear ion trap mass spectrometry (LC-ITMSn ) and high-resolution tandem mass spectrometry (LC-HRMS/MS). Metabolites of colchicine could be identified in urine for confirmation of screening results. Gas chromatography–mass spectrometry (GC-MS) analysis was also conducted, but colchicine could not be detected. Furthermore, colchicine concentration was estimated via LC-HRMS/MS in plasma samples. Results of the systematic screening indicated the ingestion of colchicine from both subjects. In both cases, the parent compound was detected in blood plasma and urine using the LC-HRMS/MS and LC-ITMSn system. An O-demethylation metabolite was identified in urine samples of both subjects using LC-HRMS/MS; the N-deacetylation product was also found in urine samples of both cases via LC-HRMS/MS and LC-ITMSn . The use of LC-ITMSn resulted only in the detection of the O-demethylation product in case 2. Plasma concentrations were estimated at 2.5 ng/ml and 4.7 ng/ml for cases 1 and 2, respectively. We demonstrated the detection of this highly toxic alkaloid in blood plasma and urine using a time-saving and reliable clinical systematic screening. Furthermore, we identified metabolites of colchicine being rarely discussed in literature, which can be used as additional screening targets.
DOI of the first publication: 10.1002/dta.3160
URL of the first publication: https://doi.org/10.1002/dta.3160
Link to this record: urn:nbn:de:bsz:291--ds-411406
hdl:20.500.11880/36925
http://dx.doi.org/10.22028/D291-41140
ISSN: 1942-7611
1942-7603
Date of registration: 22-Nov-2023
Description of the related object: Supporting Information
Related object: https://analyticalsciencejournals.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fdta.3160&file=dta3160-sup-0001-2021_ACV_Colchicin_DTA_ESM_1.pdf
Faculty: M - Medizinische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
Professorship: M - Prof. Dr. Markus Meyer
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes



This item is licensed under a Creative Commons License Creative Commons